Drägerwerk AG & Co. KGaA (ETR:DRW3) Given a €42.24 Price Target at Warburg Research

Drägerwerk AG & Co. KGaA (ETR:DRW3Get Rating) has been given a €42.24 ($45.91) price target by investment analysts at Warburg Research in a research note issued on Wednesday, Borsen Zeitung reports. Warburg Research’s target price indicates a potential downside of 3.01% from the stock’s current price.

Separately, Jefferies Financial Group set a €36.00 ($39.13) price target on shares of Drägerwerk AG & Co. KGaA in a research report on Tuesday, January 17th.

Drägerwerk AG & Co. KGaA Stock Down 0.8 %

Shares of ETR DRW3 traded down €0.35 ($0.38) during midday trading on Wednesday, reaching €43.55 ($47.34). The company’s stock had a trading volume of 4,940 shares, compared to its average volume of 33,804. The stock has a 50 day simple moving average of €41.99 and a 200-day simple moving average of €44.59. The company has a current ratio of 1.67, a quick ratio of 0.81 and a debt-to-equity ratio of 23.87. The stock has a market capitalization of $374.53 million and a price-to-earnings ratio of 23.41. Drägerwerk AG & Co. KGaA has a fifty-two week low of €38.20 ($41.52) and a fifty-two week high of €57.75 ($62.77).

Drägerwerk AG & Co. KGaA Company Profile

(Get Rating)

Drägerwerk AG & Co KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.

Recommended Stories

Receive News & Ratings for Drägerwerk AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drägerwerk AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.